We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Soft Tissue Ultrasound of Infections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01557426
Recruitment Status : Completed
First Posted : March 19, 2012
Last Update Posted : April 29, 2015
Information provided by (Responsible Party):
Rhode Island Hospital

Brief Summary:


This study aims to characterize severe skin and soft tissue infections (SSTIs) in the emergency department through the acquisition of ultrasound images. A wide range of SSTIs will be imaged and recorded, leading to a registry of these infections. The registry will show whether ED (emergency department) sonographers can accurately characterize these infections, as compared to the final hospital diagnosis. The registry will also provide data for a case-control study comparing ultrasonographic characteristics of necrotizing skin and soft tissue infections (NSTIs) to those of non-necrotizing SSTIs.

Research procedures:

In this study, the investigators will approach patients who present to the Emergency Department with a possible skin and/or tissue infection. Study subjects must be ED patients requiring admission to the hospital for the primary problem of an SSTI due to the need for follow-up. If the patient consents to participating in the study, the investigator will obtain and record an ultrasound image of the infected area. An ultrasound image of an uninfected area of skin will also be recorded for comparison. Patient information regarding personal history, physical examination, blood tests and x-rays will also be gathered from participants.

Condition or disease Intervention/treatment Phase
Soft Tissue Infections Cellulitis Abscess Other: Ultrasound Phase 1

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Soft Tissue Ultrasound of Infections
Study Start Date : March 2012
Primary Completion Date : December 2014
Study Completion Date : March 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound
U.S. FDA Resources

Arm Intervention/treatment
Single interventional group - patients agree to an ultrasound of their skin or soft tissue infection and an ultrasound to an uninfected portion of skin.
Other: Ultrasound
A linear ultrasound transducer will be used with ultrasound gel to obtain an image of subcutaneous structures and tissues over the involved body site. Ultrasound video will be recorded whenever possible, however studies that are not recorded will still be included. Video recording will be initiated once the desired image is obtained. Appropriate measurements will be made and views identified using the features of the ultrasound machine. Scanning of the contralateral body segment will then be performed. The ultrasound probe will be thoroughly cleaned and disinfected between ultrasound scans.

Primary Outcome Measures :
  1. Discharge diagnosis [ Time Frame: 2 years ]
    Discharge diagnosis will be collected by retrospective chart review

Secondary Outcome Measures :
  1. Disposition after admission [ Time Frame: 2 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • At least 18 years of age
  • Ability to understand risks/benefits and consent to participation in the study
  • Ability to read and understand English or Spanish
  • Primary diagnosis for admission is SSTI, including cellulitis, abscess, fasciitis, myositis
  • Requiring admission to an inpatient service

Exclusion Criteria:

  • Patients in custody of law enforcement
  • Patients on a psychiatric hold

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01557426

United States, Rhode Island
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Rhode Island Hospital
Principal Investigator: Otto Liebmann, MD Rhode Island Hospital

Responsible Party: Rhode Island Hospital
ClinicalTrials.gov Identifier: NCT01557426     History of Changes
Other Study ID Numbers: 304321
First Posted: March 19, 2012    Key Record Dates
Last Update Posted: April 29, 2015
Last Verified: March 2012

Keywords provided by Rhode Island Hospital:
soft tissue

Additional relevant MeSH terms:
Communicable Diseases
Soft Tissue Infections
Pathologic Processes
Skin Diseases, Infectious
Connective Tissue Diseases